# BotulInum Toxin Type A for Peripheral Neuropathic Pain in subjEcts With Carpal Tunnel Syndrome

> **NCT05411900** · PHASE2 · UNKNOWN · sponsor: **Francesco Bono** · enrollment: 164 (estimated)

## Conditions studied

- Carpal Tunnel Syndrome
- Neurogenic Inflammation
- Pain
- Drug Use
- Neuropathic Pain

## Interventions

- **DRUG:** BoNT-A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05411900
- **Lead sponsor:** Francesco Bono
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-25
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2022-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05411900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05411900, "BotulInum Toxin Type A for Peripheral Neuropathic Pain in subjEcts With Carpal Tunnel Syndrome". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05411900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*